Meeting
2018 ASCO Quality Care Symposium
Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
Authors
Dylan M. Zylla
Park Nicollet/HealthPartners, Minneapolis, MN
Dylan M. Zylla, Grace Gilmore, Justin Eklund, Sara Richter, Anders Carlson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Studies Using Existing Registries or Databases cd
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 19)
DOI
10.1200/JCO.2018.36.30_suppl.19
Abstract #
19
Poster Bd #
D5
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Quality Care Symposium
Incidence of diabetes and hyperglycemia among patients receiving glucocorticoids with chemotherapy.
First Author: Dylan M. Zylla
Poster
2022 ASCO Annual Meeting
Immune checkpoint inhibitor–induced diabetes mellitus across NCI trials.
First Author: Zoe E. Quandt
Poster
2019 Gastrointestinal Cancers Symposium
Impact of glycemic control on treatment efficacy and safety during nabpaclitaxel plus gemcitabine therapy in unresectable pancreatic cancer.
First Author: Junko Tauchi
Poster
2018 ASCO Annual Meeting
Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses of diabetic patients from the phase II CHRONOS-1 study.
First Author: Martin H. Dreyling